UPDATED 12.06.2014 09:08

Organised cervical cancer screening programme in the Helsinki and Uusimaa health care district in Finland in the invitation year 2012. Numbers and percentage distribution of primary screening test results, referrals for further examinations, and histological diagnosis of the cervix uteri.

Screening Screened Referral Histological diagnosis
test     Invasive
carcinoma
Microinvasive
carcinoma
Carcinoma
in situ
Dysplasia
gravis
Dysplasia
moderata
Dysplasia
levis
Other or
normal
  n n % n % n % n % n % n % n % n %
Pap test1 50325 452 0.90 4 0.01 2 0.00 5 0.01 36 0.07 79 0.16 43 0.09 283 0.56
I 45851 - - - - - - - - - - - - - - - -
II 4095 108 0.21 - - - - 1 - 1 - 4 0.01 4 0.01 98 0.19
III 352 317 0.63 1 - 1 - 3 0.01 25 0.05 68 0.14 35 0.07 184 0.37
IV 26 26 0.05 3 0.01 1 - 1 - 9 0.02 7 0.01 4 0.01 1 -
V 1 1 - - - - - - - 1 - - - - - - -
Inadequate - - - - - - - - - - - - - - - - -
Unknown - - - - - - - - - - - - - - - - -
HPV test 5503 100 1.82 - - 1 0.02 1 0.02 8 0.15 15 0.27 7 0.13 68 1.24
Negative1 5080 4 0.07 - - - - - - - - - - - - 4 0.07
Positive2 423 96 1.74 - - 1 0.02 1 0.02 8 0.15 15 0.27 7 0.13 64 1.16
Total 55828 552 0.99 4 0.01 3 0.01 6 0.01 44 0.08 94 0.17 50 0.09 351 0.63

1 Women with Papanicolaou class I or II negative HPV test are not referred for further examinations unless repeated cytology or other results are suggestive of cancer.
2 Women whose HPV test is positive are referred for further examinations on the basis of cytology or a repeatedly positive result.